Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1991 1
1997 1
1998 1
1999 1
2000 1
2001 2
2002 2
2003 1
2004 6
2005 4
2006 5
2007 2
2008 7
2009 7
2010 5
2011 7
2012 8
2013 10
2014 15
2015 14
2016 10
2017 9
2018 8
2019 13
2020 11
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Results by year
Filters applied: . Clear all
Page 1
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD. Nabors LB, et al. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537-1570. doi: 10.6004/jnccn.2020.0052. J Natl Compr Canc Netw. 2020. PMID: 33152694
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, Zhang Z, Minata M, Lee Y, Sadahiro H, Yamaguchi S, Komarova S, Yang E, Markert J, Nabors LB, Bhat K, Lee J, Chen Q, Crossman DK, Shin-Ya K, Nam DH, Nakano I. Bastola S, et al. Among authors: nabors lb. Nat Commun. 2020 Sep 16;11(1):4660. doi: 10.1038/s41467-020-18189-y. Nat Commun. 2020. PMID: 32938908 Free PMC article.
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.
Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, Taphoorn MJ, Shen CC, Rao N, Thurzo L, Herrlinger U, Gupta T, Kortmann RD, Adamska K, McBain C, Brandes AA, Tonn JC, Schnell O, Wiegel T, Kim CY, Nabors LB, Reardon DA, van den Bent MJ, Hicking C, Markivskyy A, Picard M, Weller M; European Organisation for Research and Treatment of Cancer (EORTC); Canadian Brain Tumor Consortium; CENTRIC study team. Stupp R, et al. Among authors: nabors lb. Lancet Oncol. 2014 Sep;15(10):1100-8. doi: 10.1016/S1470-2045(14)70379-1. Epub 2014 Aug 19. Lancet Oncol. 2014. PMID: 25163906 Free article. Clinical Trial.
Complications from pharmacotherapy.
Nabors LB, Surboeck B, Grisold W. Nabors LB, et al. Handb Clin Neurol. 2016;134:235-50. doi: 10.1016/B978-0-12-802997-8.00014-1. Handb Clin Neurol. 2016. PMID: 26948358 Review.
An Update on Neurofibromatosis Type 1-Associated Gliomas.
Lobbous M, Bernstock JD, Coffee E, Friedman GK, Metrock LK, Chagoya G, Elsayed G, Nakano I, Hackney JR, Korf BR, Nabors LB. Lobbous M, et al. Among authors: nabors lb. Cancers (Basel). 2020 Jan 1;12(1):114. doi: 10.3390/cancers12010114. Cancers (Basel). 2020. PMID: 31906320 Free PMC article. Review.
Management of Central Nervous System Tumors.
Kaley T, Nabors LB. Kaley T, et al. Among authors: nabors lb. J Natl Compr Canc Netw. 2019 May 1;17(5.5):579-582. doi: 10.6004/jnccn.2019.5012. J Natl Compr Canc Netw. 2019. PMID: 31117044
Highlights of the inaugural ten - the launch of Neuro-Oncology Advances.
Nassiri F, Aldape K, Alhuwalia M, Brastianos P, Ducray F, Galldiks N, Kim A, Lamszus K, Mitchell D, Nabors LB, Nam DH, Natsume A, Ng HK, Niclou S, Sahm F, Short S, Walsh K, Wick W, Zadeh G. Nassiri F, et al. Among authors: nabors lb. Neurooncol Adv. 2019 Aug 28;1(1):vdz016. doi: 10.1093/noajnl/vdz016. eCollection 2019 May-Dec. Neurooncol Adv. 2019. PMID: 32642652 Free PMC article. No abstract available.
144 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page